Efficacy and Tolerability of Lacosamide in the Treatment of Children With Refractory Generalized Epilepsy

Journal of Child Neurology
Chandrabhaga MiskinKaren S Carvalho

Abstract

Lacosamide is FDA-approved in patients 17 years or older with partial-onset epilepsy. We evaluated the efficacy and tolerability of lacosamide in children with refractory generalized epilepsy. We retrospectively reviewed records of 21 children with refractory generalized epilepsy treated with lacosamide in our institution from 2009-2013 divided into 2 subgroups- I, Lennox-Gastaut Syndrome, and II, other generalized epilepsies. Efficacy was defined as seizure freedom or ≥50% seizure reduction. Descriptive data analysis including seizure freedom was compared using c(2) analysis. There were eleven females and ten males with a mean age, of 11.9 years. Five patients became seizure free, nine had ≥50% seizure reduction, and seven had no response. Group I: seven had ≥50% improvement, one did not respond. Group II: five became seizure free, two had ≥50% improvement, five had no response. Lacosamide is effective and well tolerated in children with refractory generalized epilepsy particularly patients with Lennox-Gastaut Syndrome.

References

May 11, 2011·Pediatric Neurology·Laura M F F GuilhotoSanjeev V Kothare
Sep 20, 2011·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Eli HeymanRevital Gandelman-Marton
Dec 27, 2011·Epilepsy & Behavior : E&B·Andro Zangaladze, Christopher Skidmore
Jan 28, 2012·Seizure : the Journal of the British Epilepsy Association·Pegah Afra, Bola Adamolekun
Apr 3, 2012·Journal of Child Neurology·Reena Gogia Rastogi, Yu-Tze Ng
May 18, 2012·Clinical Neuropharmacology·René Andrade-MachadoEsteban Jaramillo-Jimenez
Nov 13, 2012·Journal of Child Neurology·William R YornsIgnacio Valencia
Dec 22, 2012·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Marcia L Buck, Howard P Goodkin
Jan 10, 2013·Seizure : the Journal of the British Epilepsy Association·Alberto VerrottiPaolo Curatolo
Jul 19, 2013·Annals of the New York Academy of Sciences·Pamela DotyKelly Simontacchi
Oct 17, 2013·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Salvatore GrossoPaolo Balestri
May 20, 2014·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Salvatore GrossoPaolo Balestri
Jul 24, 2014·Acta Neurologica Scandinavica·S Grosso, P Balestri

❮ Previous
Next ❯

Citations

Nov 10, 2016·Journal of Child Neurology·Edoardo FerlazzoUmberto Aguglia
Jul 28, 2018·Journal of Paediatrics and Child Health·Andrea D RüeggerA Simon Harvey
Jul 10, 2019·Acta neurologica Belgica·Serena Borrelli, Riem El Tahry
Dec 11, 2019·Epilepsia Open·Sinéad B HeavinNorman Delanty
Aug 21, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·David G VosslerUNKNOWN SP0982 co-investigators
Nov 16, 2019·Epilepsy & Behavior : E&B·Elena FonsecaManuel Toledo

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seizure : the Journal of the British Epilepsy Association
S Pradeep Kumar, Philip E M Smith
© 2022 Meta ULC. All rights reserved